A novel technique for morphometric quantification of subarachnoid hemorrhage-induced microglia activation

Journal of Neuroscience Methods

Volumn 229, Issue , 2014, Pages 44-52

  Plog, Benjamin A ^a,b   Moll, Katherine M ^a,b   Kang, Hongyi ^b   Iliff, Jeffrey J ^b   Dashnaw, Matthew L ^b   Nedergaard, Maiken ^b   Vates, G Edward ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Inflammation; Microglia; Morphology; Mouse; Subarachnoid hemorrhage

Indexed keywords

CD31 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; ENHANCED GREEN FLUORESCENT PROTEIN; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, MOUSE; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL STRUCTURE; COMPUTER PROGRAM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE LOCUS; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MICROGLIA; MICROGLIAL ACTIVATION; MORPHOMETRICS; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SUBARACHNOID HEMORRHAGE; ANIMAL; BRAIN; C57BL MOUSE; CAPILLARY; CELL COUNT; CELL SIZE; DISEASE MODEL; GENETICS; IMAGE PROCESSING; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PROMOTER REGION; RANDOMIZATION; REPRODUCIBILITY; TIME; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; BRAIN; CAPILLARIES; CELL COUNT; CELL SIZE; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MICROSCOPY, CONFOCAL; PROMOTER REGIONS, GENETIC; RANDOM ALLOCATION; RECEPTORS, CHEMOKINE; REPRODUCIBILITY OF RESULTS; SUBARACHNOID HEMORRHAGE; TIME FACTORS;

EID: 84899864847     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2014.04.001     Document Type: Article

References (47)

1. Arlicot N., Petit E., Katsifis A., Toutain J., Divoux D., Bodard S., et al. Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE. Eur J Nucl Med Mol Imaging 2010, 37:2371-2380.
2. Bechmann I., Priller J., Kovac A., Böntert M., Wehner T., Klett F.F., et al. Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages. Eur J Neurosci 2001, 14:1651-1658.
3. Benavides J., Quarteronet D., Imbault F., Malgouris C., Uzan A., Renault C., et al. Labelling of peripheral-type benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative kinetic studies and autoradiographic localization. J Neurochem 1983, 41:1744-1750.
4. Cahill J., Zhang J.H. Subarachnoid hemorrhage is it time for a new direction?. Stroke 2009, 40:S86-S87.
5. Crowley R.W., Medel R., Dumont A.S., Ilodigwe D., Kassell N.F., Mayer S.A., et al. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 2011.
6. David S., Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 2011.
7. Dóczi T.P. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2001, 32:817.
8. Dreier J.P. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 2011, 17:439-447.
9. Dreier J.P., Ebert N., Priller J., Megow D., Lindauer U., Klee R., et al. Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats a model for delayed ischemic neurological deficits after subarachnoid hemorrhage?. J Neurosurg 2000, 93:658-666.
10. Dreier J.P., Woitzik J., Fabricius M., Bhatia R., Major S., Drenckhahn C., et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006, 129:3224-3237.
11. Dumont A.S., Dumont R.J., Chow M.M., Lin C.-L., Calisaneller T., Ley K.F., et al. Cerebral vasospasm after subarachnoid hemorrhage putative role of inflammation. Neurosurgery 2003, 53:123-133. [discussion 33-5].
12. Friedrich V., Flores R., Muller A., Sehba F.A. Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage. Brain Res 2010, 1354:179-187.
13. Frijns C.J.M., Kappelle L.J. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002, 33:2115-2122.
14. Graeber M.B. Changing face of microglia. Science (New York, NY) 2010, 330:783-788.
15. Hansen-Schwartz J., Vajkoczy P., Macdonald R.L., Pluta R.M., Zhang J.H. Cerebral vasospasm looking beyond vasoconstriction. Trends Pharmacol Sci 2007, 28:252-256.
16. Iliff J.J., Wang M., Liao Y., Plog B.A., Peng W., Gundersan G.A., et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial soluted, including amyloid β. Sci Transl Med 2012, 4:1-11.
17. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000, 20:4106-4114.
18. Kozlowski C., Weimer R.M. An automated method to quantify microglia morphology and application to monitor activation state longitudinally in vivo. PLOS ONE 2012, 7:1-9.
19. Koźniewska E., Michalik R., Rafałowska J., Gadamski R., Walski M., Frontczak-Baniewicz M., et al. Mechanisms of vascular dysfunction after subarachnoid hemorrhage. J Physiol Pharmacol 2006, 57(Suppl. 11):145-160.
20. Lawson L.J., Perry V.H., Dri P., Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39:151-170.
21. Liu W., Tang Y., Feng J. Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system. Life Sci 2011.
22. Macdonald R.L., Pluta R.M., Zhang J.H. Cerebral vasospasm after subarachnoid hemorrhage the emerging revolution. Nat Clin Pract Neurol 2007, 3:256-263.
23. Murakami K., Koide M., Dumont T.M., Russell S.R., Tranmer B.I., Wellman G.C. Subarachnoid hemorrhage induces gliosis and increased expression of the pro-inflammatory cytokine high mobility group box 1 protein. Transl Stroke Res 2011, 2:72-79.
24. Ostrowski R.P., Colohan A.R., Zhang J.H. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 2006, 28:399-414.
25. Peng W., Cotrina M.L., Han X., Yu H., Bekar L., Blum L., et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci U S A 2009, 106:12489-12493.
26. Perkins E., Kimura H., Parent A.D., Zhang J.H. Evaluation of the microvasculature and cerebral ischemia after experimental subarachnoid hemorrhage in dogs. J Neurosurg 2002, 97:896-904.
27. Pluta R.M., Hansen-Schwartz J., Dreier J., Vajkoczy P., Macdonald R.L., Nishizawa S., et al. Cerebral vasospasm following subarachnoid hemorrhage time for a new world of thought. Neurol Res 2009, 31:151-158.
28. Prinz M., Priller J. Tickets to the brain role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J Neuroimmunol 2010, 224:80-84.
29. Rangroo-Thrane V., Thrane A.S., Chanag J., Alleluia V., Nagelhus E.A., Nedergaard M. Real-time analysis of microglial activation and motility in hepatic and hyperammonemic encephalopathy. Neuroscience 2012, 220:247-255.
30. Ransohoff R.M., Cardona A.E. The myeloid cells of the central nervous system parenchyma. Nature 2010, 468:253-262.
31. Rosengart A.J., Schultheiss K.E., Tolentino J., Macdonald R.L. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007, 38:2315-2321.
32. Sehba F.A., Bederson J.B. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res 2006, 28:381-398.
33. Sehba F.A., Friedrich V. Early micro vascular changes after subarachnoid hemorrhage. Acta Neurochir Suppl (Wien) 2011, 110:49-55.
34. Sehba F.A., Friedrich V., Makonnen G., Bederson J.B. Acute cerebral vascular injury after subarachnoid hemorrhage and its prevention by administration of a nitric oxide donor. J Neurosurg 2007, 106:321-329.
35. Sehba F.A., Mostafa G., Friedrich V., Bederson J.B. Acute microvascular platelet aggregation after subarachnoid hemorrhage. J Neurosurg 2005, 102:1094-1100.
36. Sehba F.A., Mostafa G., Knopman J., Friedrich V., Bederson J.B. Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg 2004, 101:633-640.
37. Sehba F.A., Pluta R.M., Zhang J.H. Metamorphosis of subarachnoid hemorrhage research from delayed vasospasm to early brain injury. Mol Neurobiol 2011, 43:27-40.
38. Sercombe R., Dinh Y.R.T., Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol 2002, 88:227-249.
39. Simi A., Tsakiri N., Wang P., Rothwell N.J. Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans 2007, 35:1122-1126.
40. Soltys Z., Orzylowska-Sliwinska O., Zaremba M., Orlowski D., Piechota M., Fiedorowicz A., et al. Quantitative morphological study of microglial cells in the ischemic rat brain using principal component analysis. J Neurosci Methods 2005, 146:50-60.
41. Sotys Z., Ziaja M., Pawliski R., Setkowicz Z., Janeczko K. Morphology of reactive microglia in the injured cerebral cortex. Fractal analysis and complementary quantitative methods. J Neurosci Res 2001, 63:90-97.
42. Suarez J.I., Tarr R.W., Selman W.R. Aneurysmal subarachnoid hemorrhage. N Engl J Med 2006, 354:387-396.
43. Vergouwen M.D.I., Ilodigwe D., Macdonald R.L. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 2011.
44. Yenari M.A., Kauppinen T.M., Swanson R.A. Microglial activation in stroke therapeutic targets. Neurotherapeutics 2010, 7:378-391.
45. Yrjänheikki J., Keinänen R., Pellikka M., Hökfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 1998, 95:15769-15774.
46. Yrjänheikki J., Tikka T., Keinänen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 1999, 96:13496-13500.
47. Zhang Z., Chopp M., Powers C. Temporal profile of microglial response following transient (2h) middle cerebral artery occlusion. Brain Res 1997, 744:189-198.